Intellectual Property India Publishes Patent Application for A Causal Inference-Driven Artificial Intelligence Platform For Personalized Immunotherapy Response Prediction And Treatment Optimization In Oncology

MUMBAI, India, June 22 -- Intellectual Property India has published a patent application (202641069495 A) filed by Mr. Ratheesh Kumar Radhakrishnan on June 03, 2026, for A Causal Inference-Driven Artificial Intelligence Platform For Personalized Immunotherapy Response Prediction And Treatment Optimization In Oncology.

Inventor includes Mr. Ratheesh Kumar Radhakrishnan.

The application for the patent was published on June 12, 2026, under issue no. 24/2026.

Abstract: The present system discloses a Causal Multi-Modal Immunotherapy Response Prediction and Optimization Method (CMIRPOM) implemented through a causal inference-driven artificial intelligence platform for personalized cancer immunotherapy. The invention integrates heterogeneous bi...